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Methanol is a large volume industrial chemical and widely used
solvent and fuel additive. Methanol’s well known toxicity and use
in a wide spectrum of applications has raised long-standing
environmental issues over its safety, including its carcinogenicity.
Methanol has not been listed as a carcinogen by any regulatory
agency; however, there are debates about its carcinogenic
potential. Formaldehyde, a metabolite of methanol, has been
proposed to be responsible for the carcinogenesis of methanol.
Formaldehyde is a known carcinogen and actively targets DNA
and protein, causing diverse DNA and protein damage. However,
formaldehyde-induced DNA adducts arising from the metabolism
of methanol have not been reported previously, largely due to
the absence of suitable DNA biomarkers and the inability to
differentiate what was due to methanol compared with the
substantial background of endogenous formaldehyde. Recently,
we developed a unique approach combining highly sensitive liquid
chromatography-mass spectrometry methods and exposure to
stable isotope labeled chemicals to simultaneously quantify
formaldehyde-specific endogenous and exogenous DNA adducts.
In this study, rats were exposed daily to 500 or 2000 mg/kg
[13CD4]-methanol by gavage for 5 days. Our data demonstrate
that labeled formaldehyde arising from [13CD4]-methanol induced
hydroxymethyl DNA adducts in multiple tissues in a dose-
dependent manner. The results also demonstrated that the number
of exogenous DNA adducts was lower than the number of
endogenous hydroxymethyl DNA adducts in all tissues of rats
administered 500 mg/kg per day for 5 days, a lethal dose to
humans, even after incorporating an average factor of 4 for
reduced metabolism due to isotope effects of deuterium-labeled
methanol into account.
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Methanol is a high volume industrial chemical that is widely
used as a solvent, fuel, or fuel additive and a starting reagent
for the synthesis of other important industrial chemicals,
such as formaldehyde (Kavet and Nauss, 1990). It is well
documented that acute exposure to high doses of methanol can
result in metabolic acidosis, ocular toxicity, and even death in
humans (Burkhart, 1997; Liesivuori and Savolainen, 1991;
Martin-Amat et al., 1978; Agency for Toxic Substances and
Disease Registry, 1993). These toxicities, coupled with wide
spread human exposure has raised long-standing public
concerns over its safety, including its developmental toxicity
and carcinogenesis. Although developmental toxicity has been
demonstrated in rodents (Rogers and Mole, 1997; Rogers et al.,
2004), there remain debates regarding the potential carcinoge-
nicity of methanol.
Methanol currently is not classified as a carcinogen by any
regulatory body or the International Agency for Research on
Cancer (Cruzan, 2009). No epidemiology studies have been
reported for methanol-exposed cohorts. Several animal
cancer bioassays have been conducted and widely discussed
in the literature (New Energy Development Organization
[NEDO], 1985a,b, 1987; Soffritti et al., 2002). The Japanese
NEDO performed inhalation carcinogenicity studies in rats,
mice, and monkeys in 1982–1984, and no positive findings
were identified. Another study in Sprague-Dawley rats was
conducted by the European Ramazzini Foundation (ERF)
(Soffritti et al., 2002). They exposed rats to 0, 500, 5000, and
20,000 ppm of methanol in drinking water for 2 years.
Significantly increased incidences for hemolymphoreticular
tumors and ear duct carcinomas were reported for animals in
the highest dose group (Soffritti et al., 2002). However, their
use of conventionally maintained animals, high incidence of
lung pathology, and potential misidentification of lung
lesions have raised serious concerns about the conclusions
drawn from this study (Cruzan, 2009; Schoeb et al., 2009b;
Schoeb and McConnell, 2011b).
Despite the inconsistent results across the studies and the
lack of substantial evidence for the mode of action (MOA) of
methanol’s carcinogenesis, two possible mechanisms were
proposed (Cruzan, 2009; Sweeting et al., 2010), as shown in
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Figure 1. The most prevalent hypothesis is that methanol’s
metabolism to formaldehyde is responsible for the carcinoge-
nicity of methanol. Methanol is metabolized to formaldehyde
in rodents and humans with the participation of different
enzyme systems (Clary, 2003; Harris et al., 2003; Johlin et al.,
1987). Humans primarily use alcohol dehydrogenase (ADH)
and cytochrome P450 2E1 (CYP2E1) to metabolize methanol,
whereas rodents use catalase to metabolize methanol to
formaldehyde. Another hypothesis is that oxidative DNA
damage from reactive oxygen species is generated during the
metabolism of methanol by catalase (Cederbaum and Qureshi,
1982).
Formaldehyde is a known carcinogen, causing squamous
cell carcinoma in nasal tissue of rats and nasopharyngeal
cancer in humans (Kerns et al., 1983; Swenberg et al., 1980).
Formaldehyde is a very reactive compound that targets DNA
and proteins, causing diverse DNA and protein damage.
However, the induction of formaldehyde-induced DNA
damage following methanol exposure has not been successfully
investigated (Wang et al., 2008), which is largely due to the
lack of suitable DNA biomarkers and the interference of
substantial endogenous background adducts of formaldehyde.
It is well documented that both methanol and its metabolite,
formaldehyde, are endogenous metabolites in animals and
humans.
Our laboratory has recently developed highly sensitive liquid
chromatography-mass spectrometry (LC-MS/MS) methods to
analyze formaldehyde-specific DNA biomarkers (Lu et al.,
2010a, 2011). Coupled with the use of stable isotope labeled–
formaldehyde for exposure, the endogenous and exogenous
formaldehyde–induced DNA adducts could be differentiated
and accurately measured for the first time. In our previous
studies, we have clearly demonstrated that exogenous formal-
dehyde induced N2-hydroxymethyl-dG adducts, but not N6-
hydroxymethyl-dA adducts, in nasal epithelium of rats and
monkeys exposed by inhalation to [13CD2]-formaldehyde,
whereas endogenous N2-hydroxymethyl-dG and N6-hydroxy-
methyl-dA were readily detected in all tissues examined (Lu
et al., 2010a).
Here, we used a similar approach by exposing rats orally to
[13CD4]-methanol through gavage for 5 days, followed by the
analysis of DNA adducts using our highly sensitive LC-MS/MS
selected reaction monitoring (SRM) methods with a limit of
detection of 20–240 amol on column. This study was specifically
designed to examine whether or not methanol-derived formalde-
hyde causes DNA damage in rats. Furthermore, we were
interested in evaluating the individual contribution of endogenous
formaldehyde and methanol-derived formaldehyde. Using our
unique approach, DNA adducts originating from both endoge-
nous and exogenous formaldehyde were quantified simulta-
neously in rats exposed to different doses of [13CD4]-methanol.
We have demonstrated that [13CD4]-methanol–derived formalde-
hyde DNA adducts were induced in multiple tissues in a dose-
dependent manner. Moreover, ratios of exogenous versus
endogenous formaldehyde DNA adducts clearly show that
endogenous DNA adducts are present in larger amounts than
are exogenous DNA adducts in rats treated with 500 or 2000
mg/kg daily for 5 days.
MATERIALS AND METHODS
Chemicals and materials. Deoxyguanosine, deoxyadenosine, potassium
phosphate, Tris-HCl, MgCl2, formic acid, NaCNBH3, methanol, acetonitrile,
phosphates, and high-performance liquid chromatography (HPLC) grade water
were all purchased from Sigma (St Louis, MO). Twenty percent of
formaldehyde in water was procured from Tousimis (Rockville, MD). DNase
I, alkaline phosphatase, and phosphodiesterases were purchased from Sigma.
[13C10
15N5]-dG was ordered from Cambridge Isotope Lab (Cambridge, MA).
N2-CH3-dG and N
6-Me-dA was obtained from Berry & Associates (Dexter,
MI). All chemicals were used as received unless otherwise stated.
Preparation of internal standards. A 10mM [13C10
15N5]-dG and [
15N5]-
dA were mixed with 100mM formaldehyde in phosphate buffer (pH ¼ 7.2)
overnight at 37C. The reaction mixture was separated by HPLC using a 150 3
2.5 mm C18 T3 analytical column. N2-Hydroxymethyl-dG and N6-hydrox-
ymethyl-dA were collected, followed by incubation with 50mM NaCNBH3





6-CH3-dA eluted at 27.2 and






6-CH3-dA was determined by HPLC with corresponding
unlabeled N2-CH3-dG and N
6-Me-dA as references. The conversion rate from
hydroxymethyl to methyl groups was ~65 to 85%.
Exposure experiment. Eight Sprague-Dawley rats were exposed to
[13CD4]-methanol at 500 or 2000 mg/kg/day by gavage for 5 days. Control
animals received saline. Liver, lung, kidney, spleen, bone marrow, thymus,
brain, and white blood cells (WBC) were collected 6 h following the last
dosing, flash frozen, and stored at 80C until analysis.
DNA isolation, treatment, and digestion. DNA was isolated from tissues
of rats using a NucleoBond DNA Isolation Kit (Bethlehem, PA) according to
the manufacturer’s instruction. The isolated DNA was dissolved in water,
quantified by UV spectroscopy, and frozen at 80C for later analysis. About
FIG. 1. Metabolism of methanol and two proposed MOAs for the
carcinogenicity of methanol, adapted from Sweeting et al. (2010).
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200 lg of DNA was incubated with 50mM NaCNBH3 at 37C for 6 h in
phosphate buffer (pH ¼ 7.2). Then, DNA was treated with DNase I (200U) for
10 min in the digestion buffer (80mM Tris-HCl and 20mM MgCl2, pH ¼ 7.2),
followed by the addition of 25 ll of alkaline phosphatase and 25 ll of
phosphodiesterases for an additional hour. Enzymes and undigested DNA were
removed by a Millipore Microcon YM-10 spin column, and the resultant
solution was separated by HPLC to collect the fractions containing the
corresponding DNA adducts.
High performance liquid chromatography. The purification of formal-
dehyde-DNA adducts was carried out on an Agilent 1200 series HPLC system
equipped with a diode-array detector (Santa Clara, CA). Analytes were
separated by reverse phase chromatography using a 150 3 4.6 mm C18 T3
analytical column from Waters (Milford, MA). The mobile phases were 10mM
ammonium acetate with 0.1% acetic acid (A) and methanol (B). The gradient
was used as follows, at a flow rate of 1 ml/min and monitored at 254 nm: 0 min,
5% solvent B; 5 min, 5% solvent B; 10 min, 8% solvent B; 20 min, 10%
solvent B; 30 min, 15% solvent B; 45 min, 30% solvent B; 45.1 min, 5%
solvent B; and 60 min, 5% solvent B. N2-Me-dG and N6-Me-dA eluted at 26.5
and 31.7 min on the column in this system, respectively.
Liquid chromatography-mass spectrometry. LC-MS analyses were per-
formed on a triple quadrupole mass spectrometer TSQ-Quantum Ultra (Thermo
Electron, Waltham, MA) operating in SRM mode to detect and quantify
hydroxymethyl-DNA adducts. The mass spectrometer was interfaced with
a nano-Ultra Performance Liquid Chromatography system from Waters. Mobile
phases were comprised of water with 0.1% Acetic Acid (A) or Acetonitrile with
0.1% Acetic Acid (B). Both capillary and nano-flow rates were used to quantify
formaldehyde-DNA adducts. For the capillary method, a linear gradient was
run from 2 to 60% B over 10 min, at 40 ll/min. The electrospray ionization
(ESI) source was set as follows: spray voltage, 4.0 kV; capillary temperature,
300C; sheath gas pressure, 40 arbitrary units (au); and auxiliary gas pressure,
10 au. For the nano method, analytes were first retained on a trap column with
a flow rate of 5 ll/min of 2% mobile phase B, followed by transfer to the
analytical column with an initial starting condition of 2% B at 0.6 ll/min for
1 min followed by a linear gradient to 60% B over 14 min. The column was
then cleaned at 80% B for 1.5 min followed by a reequilibration for an additional
7.5 min. The analytes were introduced to the MS using positive mode ESI with
a source voltage of 2200 V and no additional gasses. The ion transfer tube was
held at 325C and skimmer offset set to zero. Scan speed was set at 0.1 s, scan
width at 1.0 m/z, and peak widths for Q1 and Q3 at 0.3 and 0.5 m/z,
respectively. Collision energy was set at 17 eV with Argon as the collision gas
set at 1.5 au. N2-HOCH2-dG was quantified as N
2-CH3-dG after reduction
using the transition of m/z 282.2/m/z 166.1, and N2-HO13CD2-dG was
quantified as N2-13CD2H-dG with the transition of m/z 285.2/m/z 169.1. Two
additional transitions, including m/z 284.2/m/z 168.1 and m/z 283.2/m/z
167.1, were also monitored in case H-D exchange occurred. Similarly, five
transitions, including m/z 266.2/m/z 150.1, m/z 269.2/m/z 153.1, m/z
271.2/m/z 150.1, m/z 268.2/152.1, and m/z 267.2/m/z 151.1, were used
to detect endogenous, exogenous, internal standard, and possible products after
H-D exchange for dA adducts, respectively. The calibration curves for
quantitation were obtained using the integrated peak area and amount of
injected analytical standard and internal standard.
Statistical analysis. Data represent mean ± SD. Unpaired Student’s t-tests
were performed with the sample size ranging from 4 to 6 for adduct analysis.
Differences were considered statistically significant if p < 0.05.
RESULTS
Method and Validation
Figure 2 illustrates the outline of the experiment design and
analytical approach for the analysis of hydroxymethyl-DNA
adducts after their reduction. The method has been described in
detail previously. Transitions to monitor potential H-D exchange
are extremely important to make peak assignments and accurate
quantitation. Therefore, the mass spectrometer was set up to
monitor the following transitions: m/z 282.2/m/z 166.1 for
N2-CH3-dG; m/z 285.2/m/z 169.1 for N
2-13CD2H-dG, and m/z
297.2/m/z 176.1 for internal standard [13C10
15N5]-N
2-CH3-dG.
Two additional transitions, including m/z 283.2/m/z 167.1 and
m/z 284.2/m/z 168.1, were used to monitor adducts that may
arise after potential H-D exchange. Likewise, for the detection of
dA adducts, the mass spectrometer was set up to monitor the
following transitions: m/z 266.2/m/z 150.1 for N6-CH3-dA;
m/z 269.2/m/z 153.1 for N6-13CD2H-dA; m/z 271.2/m/z
150.1 for internal standard [15N5]-N
6-CH3-dA; and m/z
268.2/m/z 152.1 and m/z 267.2/m/z 151.1 for products after
H-D exchange.
The typical calibration curves used for the quantitative
measurements of Me-dG and Me-dA adducts, respectively,
which have good linearity within three orders of magnitude, are
given in Supplementary figure S1. The good precision and
accuracy of this assay was validated by spiking known
amounts of analytical standards into liver DNA, as shown in
Supplementary table S1.
Establishment of Criteria for the Assignment of Adduct Peaks
Hydrogen-deuterium exchange is a well-documented phe-
nomenon for deuterium-labeled compounds. Therefore, potential
H-D exchange could occur during exposure, which has been
confirmed by a cell culture study using [13CD2]-formaldehyde
FIG. 2. Schematic representation of experiment design and analytical
approach for formaldehyde-DNA adducts from endogenous source and
[13CD4]-methanol.
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for exposure (Lu et al., 2011). Therefore, it is critical to establish
criteria to make peak assignments and accurate quantitation. For
dG adducts, if one deuterium atom was lost, the signal would
shift to m/z ¼ 284.2. If two deuterium atoms were lost, the signal
of exogenous peak could further move to m/z¼ 283.2. However,
the peak at m/z ¼ 283.2 could be also from the normal isotope
distribution of the endogenous peak at m/z ¼ 282.2. Therefore,
the ratio of peak283/167 versus peak282/166 needed to be
checked to determine if the peak283 is only the consequence of
natural abundance of isotopes.
Figure 3 gives the natural abundance of different isotope
peaks for spiked analytical standards, as reveled by multiple
SRM scans. Me-dG analytical standard could give two isotope
peaks at m/z¼ 284 and 283, whereas Me-dA analytical standard
only shows a single isotope peak at m/z ¼ 267. Using analytical
standards (n ¼ 20) and control DNA samples (n ¼ 40), the peak
ratios were determined to be 8.3 ± 0.6% (peak283/peak282) and
6.5 ± 1.3% (peak284/peak283) for Me-dG adducts. The peak
ratio was determined to be 8.4 ± 0.5% (only peak267 and
peak266 were observed) for dA adducts. Therefore, 9 and 8%
were selected as threshold values to justify the formation of
exogenous dG adducts, whereas 9% was used for exogenous
dA adducts if H-D exchange occurred. The specific decision
rules are illustrated in Supplementary figure S2. Briefly, if
a peak at 285 is detected, it could be unequivocally assigned to
exogenous dG adducts. If the peak at 285 is absent and peaks at
284 and 283 are detected, the peak ratios are used to make
assignments. Similarly, the peaks at 269 and 268 unambigu-
ously identify the formation of exogenous dA adducts, whereas
the ratio of 267/266 is used for the identification of adducts
if only the peak at 267 is observed. Likewise, the quantitation
of DNA adducts also needs to consider the contributions of
natural isotope abundance and H-D exchange.
Formation of N2-Hydroxymethyl-dG DNA Adducts From
Endogenous Sources and [13CD4]-Methanol
Figure 4 shows the LC-ESI-MS/MS SRM chromatograms of
N2-Me-dG DNA adducts in spleen of rats exposed to [13CD4]-
methanol for 5 days. The peak corresponding to the specific
transition of m/z 282.2/m/z 166.1 and the same retention time
with [13C10
15N5]-N
2-CH3-dG internal standard unambiguously
identified endogenous formaldehyde–induced N2-HOCH2-dG,
as shown by the peak at 12.2 min in the top panel of Figure 4.
The signal corresponding to the transition of m/z 285.2/m/z
169.1 coeluted with the internal standard, which is attributed to
N2-HO13CD2-dG arising from exogenous [
13CD4]-methanol–
derived formaldehyde, as shown in Figure 4C. In addition to
these three peaks, two more transitions, including m/z
284.2/m/z 168.1 and m/z 283.2/m/z 167.1, were also
monitored to examine whether significant H-D exchange
occurred during exposure. There is no peak at m/z 285.2 in
the 500 mg/kg dose group, as shown in Figure 4B. However,
the peak ratio of 284/283 (~38%) is significantly higher than
8%, the threshold for the identification of adducts. This clearly
demonstrated the formation of [13CD4]-methanol–derived
DNA adducts and significant H-D exchange during 5-days
exposure. Likewise, the peak ratios of 285/284, 284/283, and
FIG. 3. Contribution of natural abundance of isotope peaks for 100 fmol N2-methyl-dG (A) and 40 fmol N6-methyl-dA analytical standards injected on
column (B).
HYDROXYMETHYL DNA ADDUCTS FROM METHANOL 31
283/282 are 35, 62, and 18% for rats treated with 2000 mg/kg
methanol, as shown in Figure 4C. These numbers are all much
higher than the cutoff values arising from natural isotope
abundance, further supporting the formation of exogenous
DNA damage from [13CD4]-methanol–derived formaldehyde
and the occurrence of H-D exchange during exposure.
Formation of N6-Hydroxymethyl-dA From Endogenous
Sources and [13CD4]-Methanol
Figure 5 shows the LC-ESI-MS/MS SRM chromatogram of
N6-methyl-dA in bone marrow DNA of rats exposed to
[13CD4]-methanol for 5 days. The peak corresponding to the
specific transition of m/z 266.2/m/z 150.1 and the same
retention time with [15N5]-N
6-CH3-dA internal standard un-
equivocally identified endogenous formaldehyde–induced N6-
HOCH2-dA, as shown by the peak at 11.1 min in the top panel
of Figure 5. The signal corresponding to the transition of m/z
269.2/m/z 153.1 are generally attributed to N6-HO13CD2-dA
arising from exogenous [13CD4]-methanol–derived formalde-
hyde. However, as shown in Figure 5B, no peak was observed
for the transition at m/z 269.2/m/z 153.1. The peak at m/z 268
was able to identify the formation of exogenous dA adducts, as
we discussed above. Moreover, the ratio of peak268/152 versus
peak267/151 was 72%, which further demonstrated this peak
was primarily from exogenous exposure instead of the
consequence of natural isotope distribution (~8 to 9%).
Similarly, as the consequence of H-D exchange, the peak
ratios of 269/268, 268/267, and 267/266 in the sample from the
2000 mg/kg group were 22, 215, and 13%, separately, which
are all above the natural abundance of isotope peaks (Fig. 5C).
Numbers of Hydroxymethyl-DNA Adducts in Rats Exposed to
[13CD4]-Methanol
Table 1 summarizes the number of dG adducts in the tissues
examined. [13CD4]-methanol–derived exogenous dG adducts
were detected in all tissues except brain. It should be noticed
that these adduct numbers and others were directly calculated
from our mass spectrometry data without any adjustment based
on the isotope effect of deuterium-labeled methanol on
metabolism, unless otherwise stated. The potential influence
of isotope effects on adduct formation and corresponding
adjustment are described in the ‘‘Discussion’’ and ‘‘Conclu-
sion’’ sections. The numbers of exogenous N2-hydroxymethyl-
dG adducts induced by [13CD4]-methanol were shown to be
0.08 ± 0.08, 0.13 ± 0.04, 0.12 ± 0.04, 0.19 ± 0.12, 0.37 ± 0.08,
0.16 ± 0.06, and 0.09 ± 0.03 adducts/107 dG in liver, lung,
kidney, spleen, bone marrow, thymus, and WBC of rats treated
with 500 mg/kg/day [13CD4]-methanol, respectively. The
exogenous adduct numbers were determined to be 0.41 ±
0.14, 0.22 ± 0.06, 0.39 ± 0.09, 0.90 ± 0.26, 1.42 ± 0.29,
0.42 ± 0.03, and 0.19 ± 0.02 adducts/107 dG in liver, lung,
kidney, spleen, bone marrow, thymus, and WBC of 2000 mg/
FIG. 4. Typical LC-ESI-MS/MS SRM chromatograms of N2-Me-dG DNA adducts in spleen of rats exposed to 0 (A), 500 (B) or 2000 (C) mg/kg for 5 days.
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kg/day [13CD4]-methanol–treated rats. Clearly, methanol in-
duced the formation of exogenous dG adducts in a dose-
dependent manner. Interestingly, endogenous dG adducts also
significantly increased in liver, lung, kidney, spleen, and
thymus compared with control, whereas no increase in
endogenous dA adducts was observed following exposure.
In contrast, [13CD4]-methanol–derived exogenous dA
adducts were only observed in bone marrow and kidney, as
listed in Table 2. The number of exogenous N6-hydroxy-
methyl-dA adducts induced by [13CD4]-methanol were 0.10 ±
0.08 and 0.29 ± 0.09 adducts/107 dA in bone marrow of rats in
500 or 2000 mg/kg/day groups, respectively. The amount of
exogenous dA adducts in kidney was detectable but not
quantifiable by our capillary LC method. Therefore, a more
sensitive nano-LC method was used to quantify adducts in the
different regions of kidney, as discussed below. Typically, the
numbers of exogenous dA adducts in kidney were ~0.1 and
~0.6 adducts/107 dA in rats treated with 500, or 2000 mg/kg
[13CD4]-methanol for 5 days. The observation that exogenous
dA adducts only formed in bone marrow and kidney may
suggest fundamental differences in the formation of dA versus
dG adducts, which were found in most examined tissues. In
FIG. 5. Typical LC-ESI-MS/MS SRM chromatograms of N6-Me-dA DNA adducts in bone marrow of rats exposed to 0 (A), 500 (B) or 2000 (C) mg/kg for 5
days.
TABLE 1
N2-Hydroxymethyl-dG Adducts in Rats Exposed to 0, 500, or 2000 mg/kg Methanol for 5 Days
Dose Liver Lung Kidney Spleen Bone marrow Thymus WBC Brain
Control
Endogenous 4.35 ± 1.01 4.55 ± 1.93 4.31 ± 2.4 3.70 ± 1.34 2.99 ± 0.56 2.55 ± 0.37 3.32 ± 0.45 6.69 ± 2.91
Exogenous nd nd nd nd nd nd nd nd
500 mg/kg/day
Endogenous 5.66 ± 0.52* 7.24 ± 1.95 8.48 ± 1.50* 5.85 ± 1.12* 2.99 ± 0.73 3.49 ± 0.12* 3.65 ± 0.43 7.95 ± 2.37
Exogenous 0.08 ± 0.08 0.13 ± 0.04 0.12 ± 0.04 0.19 ± 0.12 0.37 ± 0.08 0.16 ± 0.06 0.09 ± 0.03 nd
2000 mg/kg/day
Endogenous 8.14 ± 2.03* 10.32 ± 1.83* 7.86 ± 2.14* 4.89 ± 0.69* 3.34 ± 0.49 3.73 ± 0.17* 3.92 ± 0.25 10.38 ± 4.84
Exogenous 0.41 ± 0.14 0.22 ± 0.06 0.39 ± 0.09 0.90 ± 0.26 1.42 ± 0.29 0.42 ± 0.03 0.19 ± 0.02 nd
Note. nd, nondetectable.
*Significantly different from control (p < 0.05).
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addition, both endogenous dG and dA adducts were readily
detected across all tissues analyzed.
Dose-Response of Exogenous DNA Adducts
Figure 6A illustrates the exogenous adduct numbers for dG
adducts in tissues of rats exposed to 500 mg/kg, or 2000 mg/kg
methanol for 5 days. The exogenous dG adducts ranged from
0.08 to 0.37 adducts/107 dG for 500 mg/kg treated rats,
whereas 2000 mg/kg methanol exposures induced 0.19–1.42
exogenous adducts/107 dG in different tissues. Bone marrow
had the highest amounts of exogenous dG adducts, followed by
spleen of rats exposed to methanol. The formation of
exogenous dG adducts was less than linear, suggesting
saturation of metabolism in lung, kidney, and thymus. An
approximately linear dose-response was observed for other
organs, as illustrated in Figure 6A.
Figure 6B shows the ratios of exogenous versus endogenous
dG adducts in multiple tissues, which was calculated using the
average adduct numbers of the same dose groups. The ratios
give relatively larger values for bone marrow, spleen, and
thymus, whereas the numbers for liver, lung, kidney, and WBC
are typically 1–3-fold lower. Among all the tissues, the ratios in
bone marrow were the largest in both 500 and 2000 mg/kg/day
exposure groups. However, exogenous adducts were still less
than endogenous adducts in all organs evaluated, even in rats
treated with 2000 mg/kg daily for 5 days.
Adduct Formation in Different Regions of Kidney
As methanol is partially excreted through the kidney at high
doses, exogenous DNA adducts were analyzed to evaluate
adduct distribution within the kidney. Figure 7 illustrates the
difference for the formation of exogenous adducts at the
different locations of kidney. There was no statistically
significant difference between cortex and medulla for either
exogenous dG or dA adducts in rats exposed to 500 mg/kg
methanol for 5 days (Fig. 7A). However, more exogenous dG
and dA adducts formed in cortex than medulla when rats were
exposed to 2000 mg/kg methanol for 5 days (p < 0.05,
TABLE 2
N6-Hydroxymethyl-dA Adducts in Rats Exposed to 500 or 2000 mg/kg Methanol for 5 Days
Dose Liver Lung Kidney Spleen Bone marrow Thymus WBC Brain
Control
Endogenous 1.40 ± 0.51 1.85 ± 0.19 1.19 ± 0.45 1.68 ± 0.25 1.65 ± 0.85 1.05 ± 0.25 2.53 ± 0.69 2.00 ± 1.59
Exogenous nd nd nd nd nd nd nd nd
500 mg/kg/day
Endogenous 1.48 ± 0.29 1.72 ± 0.28 1.33 ± 0.65 1.75 ± 0.49 1.07 ± 0.37 1.24 ± 0.16 1.43 ± 0.32 1.86 ± 0.61
Exogenous nd n.d. nd nd 0.10 ± 0.08 nd nd nd
2000 mg/kg/day
Endogenous 1.89 ± 0.44 1.75 ± 0.23 1.00 ± 0.16 1.82 ± 0.54 1.01 ± 0.16 1.66 ± 0.51 1.71 ± 0.30 2.08 ± 1.04
Exogenous nd nd Detectablea nd 0.29 ± 0.09 nd nd nd
Note. nd, nondetectable.
aDetectable but not quantifiable by our capillary LC method.
FIG. 6. The number of exogenous N2-hydroxymethyl-dG adducts in different tissues (A) and the ratios of exogenous versus endogenous dG adducts (B).
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Fig. 7B). This interesting observation suggests differential
exposure, metabolism, or excretion of methanol in kidney as
the dose increases.
DISCUSSION AND CONCLUSIONS
In this study, we have applied our highly sensitive LC-ESI-
MS/MS SRM methods to detect hydroxymethyl-DNA adducts
in rats exposed to 500 mg/kg, or 2000 mg/kg [13CD4]-methanol
for 5 days. Both exogenous and endogenous DNA adducts
were quantified simultaneously in the same samples. Our
results show exogenous hydroxymethyl-dG adducts formed in
multiple tissues we examined. In addition, we have demon-
strated that [13CD4]-methanol induced exogenous dA adducts
in kidney and bone marrow. Moreover, the ratios of exogenous
versus endogenous DNA adducts indicate that endogenous
hydroxymethyl-DNA adducts are greater than those generated
from [13CD4]-methanol.
Methanol currently is not listed as a carcinogen by the
International Agency for Research on Cancer, the National
Toxicology Program (NTP), or the U.S. Environmental Pro-
tection Agency (EPA). Likewise, there have been no evaluations
of cancer in human epidemiology studies. Discussions on the
potential carcinogenicity of methanol are largely focused on
several animal cancer bioassays, including NEDO and ERF
studies (NEDO, 1985a,b, 1987; Soffritti et al., 2002). However,
conflicting results have been reported from these long-term
rodent cancer bioassays. Thus, the carcinogenicity of methanol
remains unclassifiable.
The Japanese NEDO conducted a series of bioassays in rats,
mice, and monkeys following inhalation exposure (NEDO,
1985a,b, 1987). Among these studies, a 24-month carcinoge-
nicity bioassay was conducted, in which 52 F344 rats/sex/
group were exposed to 0, 10, 100, or 1000 ppm methanol
vapor. In the original reports by NEDO, no statistical
significance on cancer induction was reported due to exposure
to methanol. However, recently, EPA reanalyzed the results
and identified potential treatment-related changes in the lungs
of male rats and the adrenal medulla of female rats in the more
detailed translation of the original report. Specifically, the
observed incidence rate for pulmonary adenoma/adenocarci-
noma in high-dose males of 13.5% (7/52) was significantly
elevated (p < 0.05) over the concurrent control rate of 2%
(1/52) and historical control rates of 2.5 ± 2.6% (n ¼ 1054) and
3.84 ± 2.94% (n ¼ 1199) reported by NTP for the pre-1995
control F344 male rats fed NIH-07 diet and post-1994 control
F344 male rats fed NTP-2000 diet, respectively. Also, the
incidence of pheochromocytomas in female rats exhibited
a significant dose-response trend (p < 0.05).
The ERF conducted a drinking water study by Soffritti et al.
(2002) exposing 100 male and 100 female Sprague-Dawley
rats to 0, 500, 5000, or 20000 ppm (or 0, 53.2, 524, and 1780
mg/kg day for males and 0, 66.0, 624.1, and 2177 mg/kg day
for females) methanol in drinking water for 2 years. The rats
were kept for their lifetime (up to 153 weeks). Compared with
the control group, increased incidences of hemolymphoretic-
ular tumors as well as ear duct carcinomas were reported.
Specifically, the incidence of hemolymphoreticular tumors
(lymphomas/leukemias) was 28 and 40% for female and male
rats treated with 2177 and 1780 mg/kg methanol for 2 years,
which were higher than the incidence of 13.3 and 20.6% in
female historical controls (2274 rats) and male historical
controls (2265 rats), respectively. In addition, a significant
increase in the high-dose male ear duct carcinomas was also
reported. However, this study has been criticized due to the
ERF’s refusal to have it peer reviewed (Schoeb et al., 2009a,b),
and the finding that the majority of hemolymphoreticular
cancers were found in the lungs. A recent review by the NTP
had major differences in diagnoses and raised serious concerns
regarding the misdiagnosis of lung infections as hemolym-
phoreticular cancers (Schoeb and McConnell, 2011a,b).
Although available data on methanol carcinogenicity are
highly controversial and there are no consistent carcinogenic
responses between the NEDO and ERF studies, two MOAs
have been proposed for the carcinogenicity of methanol.
FIG. 7. Formation of exogenous hydroxymethyl-dG (A) and -dA adducts (B) in different regions of kidney.
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Formaldehyde is considered a mutagenic metabolite of
methanol and is a known carcinogen. Both genotoxicity and
cytotoxicity are key events in formaldehyde’s carcinogenicity.
Another possible MOA is oxidative stress induced by hydrogen
peroxide arising from metabolism of methanol by catalase.
However, recent studies have shown that a 6-h methanol
exposure (2000 mg/kg ip) in mice, rabbits and monkeys did not
cause increased oxidative DNA damage in lung, liver, kidney,
bone marrow, or spleen in any of these species (McCallum et al.,
2011b). Chronic treatment of mice with 2000 mg/kg daily for 15
days also did not result in increased amounts of oxidative DNA
adducts in these tissues (McCallum et al., 2011a).
In this study, we have clearly demonstrated that oral
exposure to methanol induces exogenous DNA adducts at
multiple tissues in rats treated by 500, or 2000 mg/kg daily for
5 days. The mean number of exogenous dG adducts was 0.08–
0.37 and 0.19–1.42 adducts/107 dG for 500 and 2000 mg/kg
groups, respectively. Interestingly, the number of endogenous
dG adducts also increased 1.3- to 2.3-fold, whereas no increase
in endogenous dA adducts was observed. Increased endoge-
nous dG adducts could be the consequence of saturation of
formaldehyde detoxification pathways. In addition, the marked
contrast between endogenous dG and dA adducts may also
reflect the involvement of different repair systems. This study
provided the first evidence that the metabolite of methanol,
formaldehyde, can cause DNA damage at multiple organs.
Since the formation of DNA adducts is a potential key event
during carcinogenesis, it is important to keep the dose-response
for both exogenous and endogenous DNA adducts from
formaldehyde in perspective. Considerable amounts of endog-
enous DNA damage are always present in cells, and this
background damage, like its exogenous counterpart, would be
expected to be involved in the induction of cancer. Therefore, it
is more informative to analyze the contribution of exogenous
exposure in the context of its corresponding endogenous
background, as we have demonstrated in a recent perspective
on the relationship between endogenous and exogenous DNA
adducts in risk assessment (Swenberg et al., 2011). In this
study, as shown in Figure 6, the number of exogenous DNA
adducts are less than endogenous DNA adducts in tissues we
analyzed. Bone marrow had the highest ratio of exogenous
versus endogenous dG adducts, with 0.12 and 0.43 for 500 and
2000 mg/kg groups, respectively. Placing this in a more
general perspective, if a rat took the mean dose of methanol
from dietary intake of aspartame (~0.7 mg/kg in humans), the
ratio would be 0.00016 for bone marrow, i.e., 1 exogenous
adduct out of ~6000 identical endogenous adducts.
Furthermore, we treated rats with 500, or 2000 mg/kg daily
for 5 days, which modeled the conditions used in the ERF
cancer bioassay (Soffritti et al., 2002). These doses are very
high and actually lethal to humans. Under normal physiological
conditions, methanol is metabolized to formaldehyde by ADH,
followed by rapid conversion to formic acid by formaldehyde
dehydrogenase and eventually carbon dioxide and water by
a folate-dependent dehydrogenase. Humans have limited
folate, which results in the accumulation of formic acid after
exposure to high doses of methanol. In contrast, rodents have
much higher capacity of folate, and metabolism of methanol
can occur through both catalase- and folate-dependent path-
ways. Thus, they have much higher tolerance for high amounts
of methanol by efficiently preventing the formic acid
accumulation. However, even under such high concentrations
of exposure, the endogenous DNA adducts were higher than
corresponding exogenous adducts in all tissues we analyzed.
This study shows that exogenous DNA adducts are formed
in a dose-dependent manner. The doses used in our study, 500,
or 2000 mg/kg, are below and above the documented saturation
dose (600 mg/kg) for rats (NEDO, 1987). The numbers of
exogenous dG DNA adducts in liver, lung, kidney, spleen,
bone marrow, thymus, and WBC of animals treated with 2000
mg/kg were 5.1, 1.69, 3.25, 4.74, 3.84, 2.63, and 2.11 times
higher than those in the 500 mg/kg dose group. The exogenous
dA adducts in bone marrow and kidney of rats exposed to 2000
mg/kg methanol were also several fold higher than those
exposed to 500 mg/kg methanol. These data clearly demon-
strate that higher doses of exposure lead to increased numbers
of exogenous DNA damage, although it has been reported that
the conversion of methanol to formaldehyde in rats is saturated
at doses above 600 mg/kg.
Unlike formaldehyde inhalation exposures, we detected both
exogenous dG and dA adducts in select tissues in this study,
whereas only exogenous dG could be found following
inhalation exposure. This clear difference supports our
hypothesis that exogenous dG and dA adducts are formed
through different mechanisms. Specifically, we hypothesize
that the difference could be a consequence of their different
involvement in the formation of DNA-protein cross-links
(DPC)- or DNA-protein interaction and suggest that exogenous
dG adducts are actually formed through DPC intermediates.
Our previous study demonstrated that dG actively forms DPC
through cross-linking with lysine and cysteine, whereas dA
only cross-linked with cysteine and histidine in much lower
amounts (Lu et al., 2010b). Lysine-dG cross-links are the
primary DPC formed; however, they are very unstable (Lu
et al., 2010b). Decomposition of these labile DNA-protein
cross-links may facilitate the formation of dG monoadducts.
However, this may not occur with dA because it is much less
involved in the formation of DPC. Rather, exogenous dA
adducts could be the consequence of direct reaction between
DNA and formaldehyde generated by metabolism of other
compounds. Direct inhalation exposure only leads to the
formation of exogenous dG adducts, whereas exogenous dA
adducts appear to only be formed by formaldehyde generated
from the metabolism of other formaldehyde-generating com-
pounds. This difference is of importance when evaluating the
relevance of available DNA adduct data for the risk assessment
of formaldehyde through inhalation. As we demonstrated
previously, exogenous dA adducts cannot be induced by direct
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inhalation exposure (Lu et al., 2010a) but do form through the
metabolism of other chemicals like methanol. Therefore, these
results further cast a question on the relevance of dA adducts in
risk assessment of formaldehyde inhalation exposures other
than that endogenous dA adducts would also be expected to
increase mutations when DNA replication is increased by
formaldehyde’s cytotoxicity.
In contrast to our previous formaldehyde inhalation studies,
exogenous DNA damage was found in multiple tissues, such as
liver, lung, spleen, thymus, bone marrow, kidney, and WBC
following methanol exposure. Thus, this study could be viewed
as a general positive control and further validation of the
methodology used in previous studies (Lu et al., 2010a, 2011;
Moeller et al., 2011). If the exogenous DNA adducts were
present in distant tissues, our highly sensitive method would
readily measure them, as demonstrated in this study. The huge
difference of tissue distribution of formaldehyde-DNA adducts
between formaldehyde inhalation exposure and methanol oral
exposure highlights the importance of exposure route on the
formation of DNA adducts. Formaldehyde is a very reactive
compound, and its effects are generally localized within nasal
and upper respiratory passages after inhalation. Inhaled
formaldehyde does not appear to reach distant sites in an active
form that causes DNA damage (Lu et al., 2010a; Moeller et al.,
2011). However, methanol is rapidly distributed to all organs
and metabolized thereafter once it is absorbed following
exposure. This is consistent with the systematic tissue
distribution of exogenous DNA adducts discovered in this study.
Another interesting finding was that exogenous dA adducts
were only detected in kidney and bone marrow. Bone marrow
seems to be a unique organ, with the highest exogenous/
endogenous dG adduct ratio among all the tissues we analyzed.
As we discussed above, exogenous dA adducts may only be
formed by formaldehyde generated from metabolism of related
chemicals. Therefore, higher amounts of exogenous dA adducts
might suggest greater availability of intact methanol or increased
metabolic activities, which is partially supported by the fact that
methanol is excreted by kidney after exposure to high doses of
methanol. Certainly, more studies are needed to elucidate
potential mechanisms leading to this intriguing observation.
In addition, it should be noted that there are large species
differences in the metabolism of methanol (Sweeting et al.,
2010, 2011). In humans, only ADH is involved, whereas
catalase is the primary enzyme responsible for the metabolic
activation of methanol in rodents. Moreover, the utilization of
folate is much higher in rodents, which prevents the
accumulation of formic acid. Since the tissue distribution of
hydroxymethyl-DNA adducts is largely controlled by meta-
bolic activity, the distribution spectrum of DNA adducts might
be quite different between humans and rodents after exposure
to methanol. Furthermore, although we detected exogenous
DNA adducts in multiple tissues of rats, the weight of evidence
for the genotoxicity of methanol is negative, as most previous
studies have been negative in multiple test systems.
An important issue that may influence data interpretation arises
from the rate difference between unlabeled and deuterium-labeled
methanol during metabolism. Previous studies have shown that
deuterium-labeled methanol has a slower conversion or reaction
rate (Brooks and Shore, 1971; Kraus and Simon, 2011; Shea
et al., 1983; Zhang et al., 2006), resulting in a significant isotope
effect. However, the values of isotope effects are inconsistent
among studies, ranging from 1.7 to 8.4 depending on the
experimental systems and methodologies (Brooks and Shore,
1971; Kraus and Simon, 2011; Shea et al., 1983; Zhang et al.,
2006). No experiments have been conducted exactly the same as
ours. Therefore, we used an isotope effect of 4, the mean of
reported values from several available studies, to estimate the
potential impact of deuterium on the metabolism of methanol and
subsequent adduct formation. Thus, the exogenous dG adduct
numbers and ratios of exogenous versus endogenous dG adducts
would increase approximately fourfold. Specifically, the ratio of
exogenous versus endogenous dG adducts would be 0.056, 0.072,
0.056, 0.13, 0.48, 0.18, and 0.1 in liver, lung, kidney, spleen,
thymus, bone marrow, and WBC of rats exposed to 500 mg/kg
per day for 5 days, respectively. Likewise, the ratios of exogenous
versus endogenous dG adducts in rats exposed to 2000 mg/kg
would increase to 0.20, 0.084, 0.20, 0.74, 1.70, 0.45, and 0.19 in
liver, lung, kidney, spleen, thymus, bone marrow, and WBC.
However, it should be noted that 500 mg/kg dose is already
a lethal dose to humans (estimated to be 300–1000 mg/kg). Even
at a dose lethal to humans that far exceeds environmentally
relevant concentrations, exogenous dG adducts arising from
methanol are still less than endogenous ones, if one takes an
isotope effect of 4 into account. Nevertheless, the impact of isotope
effects on exogenous adduct numbers and the ratio of exogenous
versus endogenous adducts need to be considered when applying
our data for quantitative risk assessment of methanol.
Finally, one fact to point out is that methanol and its
metabolite, formaldehyde, are both endogenous compounds.
Therefore, a substantial endogenous formaldehyde and methanol
background is always present and cannot be simply ignored.
This ever present background could and should be considered
for the risk assessment of such compounds, especially at low
doses relevant to human exposure. Two critical questions should
be asked when dealing with the risk assessment for chemicals
that form DNA adducts identical to endogenous DNA adducts.
What is the quantitative contribution of exogenous exposure to
endogenous-driven biological responses? Which exposure,
exogenous or endogenous, is driving mutagenesis or carcino-
genesis at low exposures? Knowledge of this issue should allow
science to better address a critical question, such as, what is the
safe exposure level of a chemical when substantial amounts of
the same chemical are always present in cells and tissues?
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